Brief: Endo International Launches Authorized Generic Version Of Noxafil® (Posaconazole) Oral Suspension
03/04/2023 21:31
April 3 (Reuters) - Endo International PLC ENDPQ.PK :
* ENDO LAUNCHES AUTHORIZED GENERIC VERSION OF NOXAFIL®
(POSACONAZOLE) ORAL SUSPENSION
Source text for Eikon: ID:nCNWBCbzsa
Further company coverage: ENDPQ.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes